Guselkumab (Tremfya®, Janssen, Beerse, Belgium) has been recommended for the treatment of adults with moderate-to-severe plaque psoriasis by the UK’s…

Over 150 million people have allergies in Europe, where it is the most common chronic disease,1 and in the UK the problem is particularly acute.

Lung cancer survival rates can be improved by increased sharing of best practice between different systems, according to researchers from Yale…

A new treatment for dengue fever could be developed at the end of a groundbreaking research project at the University of Nottingham, Nottingham, UK’s…

Obesity could be combatted by reducing food product portion sizes, according to researchers from the University of Liverpool, Liverpool, UK. A series of…

Acute lung injury could be treated more effectively and cheaply by two synthetic mimics of naturally occurring surfactant proteins. A study at Stanford…

Directly guiding immune cells to the centre of inflammation zones may soon become reality, as suggested by results found at the Cells-in-Motion Cluster…

Peanut allergies may soon become a thing of the past thanks to new research carried out by investigators at the University of Michigan, Ann Arbor…

New understanding into why immunity may weaken in older people, and the environmental factors that cause age-related differences in the immune system…

With Allergy Awareness Week 2018 having recently taken place from 23rd–29th April this year, EMJ caught up with the charity Allergy UK to discuss this…